2Bedikian A Y.Metastatic uveal melanoma therapy:current options[J].Int Ophthalmol Clin,2006,46(1):151-166.
3Yu H,Rohan T.Role of the insulin-like growth factor family in cancer development and progression[J].J Natl Cancer Inst,2000,92(18):1472-1489.
4LeRoith D,Roberts C T Jr.The insulin-like growth factor system and cancer[J].Cancer Lett,2003,195(2):127-137.
5Siddals K W,Marshman E,Westwood M,et al.Abrogation of insulin-like growth factor-I (IGF-I) and insulin action by mevalonic acid depletion:synergy between protein prenylation and receptor glycosylation pathways[J].J Biol Chem,2004,279(37):38353-38359.
6McCarty M F.Suppression of dolichol synthesis with isoprenoids and statins may potentiate the cancer-retardant efficacy of IGF-I down-regulation[J].Med Hypotheses,2001,56(1):12-16.
7All-Ericsson C,Girnita L,Seregard S,et al.Insulin-like growth factor-1 receptor in uveal melanoma:a predictor for metastatic disease and a potential therapeutic target[J].Invest Ophthalmol Vis Sci,2002,43(1):1-8.
8Scotlandi K,Avnet S,Benini S,et al.Expression of an IGF-I receptor dominant negative mutant induces apoptosis,inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells[J].Int J Cancer,2002,101(1):11-16.
9Andrews D W,Resnicoff M,Flanders A E,et al.Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas[J].J Clin Oncol,2001,19(8):2189-2200.
10DeBruijn D R,Allander S V,van Dijk A H,et al.The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation[J].Cancer Res,2006,66(19):9474-9482.
